Effect of left ventricular dysfunction on utilization of donor hearts

被引:24
作者
Tryon, David [1 ]
Hasaniya, Nahidh W. [1 ]
Jabo, Brice [2 ]
Razzouk, Anees J. [1 ]
Bailey, Leonard L. [1 ]
Rabkin, David G. [1 ]
机构
[1] Loma Linda Univ, Med Ctr, Dept Cardiovasc & Thorac Surg, Coleman Pavil,Suite 21121,11175 Campus St, Loma Linda, CA 92354 USA
[2] Loma Linda Univ, Med Ctr, Res Consulting Grp, Sch Publ Hlth, Loma Linda, CA USA
关键词
heart transplantation; donor heart utilization; donor heart dysfunction; BRAIN-DEATH; MYOCARDIAL DYSFUNCTION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION; OUTCOMES; IMPACT; SURVIVAL; REGISTRY; QUALITY;
D O I
10.1016/j.healun.2017.07.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: In this study we investigated modern, non-utilization rates of potential cardiac donors with left ventricular dysfunction (LVD) to clarify this phenomenon's magnitude and the impact of recent studies suggesting these organs can be safely transplanted. METHODS: Using the United Network for Organ Sharing transplant database, we reviewed all donors evaluated between January 1, 2007 and June 30, 2014. Exclusion criteria included lack of consent and age <13 or >59 years. The number of hearts not transplanted due to non-cardiac causes, structural disease, "other" (previous cardiac surgery, donation after cardiac death, etc.) and isolated LVD was determined and a covariates-adjusted Poisson regression model with robust standard errors was developed to estimate non-utilization relative risk (RR) with 95% confidence interval (CI) for LVD. Heart disposition for potential donor hearts was determined separately for 2 previous eras (1990 to 1999 and 2000 to 2006), and trends were evaluated. RESULTS: There were 60,789 donors assessed. Of the 44,829 organs meeting the inclusion criteria, 15,654 (34.92%) were transplanted and 29,175 (65.08%) were not. Of the non-utilized hearts, 15,512 (34.60%) were declined for non-cardiac reasons, 1,051 (2.34%) for structural disease, 4,073 (9.09%) for "other" and 8,539 (19.05%) exclusively for LVD. Of this last category, 4,950 (11.04%) lacked documented evidence of LVD. Covariates-adjusted RR for non-utilization showed that, for every 10% increase in LV ejection fraction, the risk of non-utilization decreased by 20% (RR = 0.80, 95% CI 0.79 to 0.81). Analysis of era-effect demonstrated significantly decreased overall utilization of donor hearts, with increases in the number of hearts not transplanted across all categories over time (p < 0.001). CONCLUSIONS: Roughly 20% of potential cardiac donors are excluded due to LVD. This figure has not been impacted by recent studies indicating that these hearts may be used safely. More complete data are required to understand why 11.04% of hearts that met inclusion criteria were refused for "poor function" without documented evidence. (C) 2018 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:349 / 357
页数:9
相关论文
共 50 条
[41]   Stent implantation in patients with severe left ventricular systolic dysfunction [J].
Briguori, Carlo ;
Aranzulla, Tiziana Claudia ;
Airoldi, Flavio ;
Cosgrave, John ;
Tavano, Davide ;
Michev, Iassen ;
Montorfano, Matteo ;
Carlino, Mauro ;
Castelli, Alfredo ;
Sangiorgi, Massimo Giuseppe ;
Colombo, Antonio .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (03) :376-384
[42]   Effect of levosimendan on renal function in background of left ventricular dysfunction: a meta-analysis of randomized trials [J].
Long, Yu-Xiang ;
Cui, Di-Yu ;
Kuang, Xue ;
Hu, Yue ;
Hu, Shuang ;
Wang, Chun-Ping ;
Liu, Zeng-Zhang .
EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) :1411-1420
[43]   Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction [J].
Docherty, Kieran F. ;
Campbell, Ross T. ;
Brooksbank, Katriona J. M. ;
Dreisbach, John G. ;
Forsyth, Paul ;
Godeseth, Rosemary L. ;
Hopkins, Tracey ;
Jackson, Alice M. ;
Lee, Matthew M. Y. ;
McConnachie, Alex ;
Roditi, Giles ;
Squire, Iain B. ;
Stanley, Bethany ;
Welsh, Paul ;
Jhund, Pardeep S. ;
Petrie, Mark C. ;
McMurray, John J. V. .
CIRCULATION, 2021, 144 (03) :199-209
[44]   Impact of Left Ventricular Diastolic Dysfunction on Lung Transplantation Outcome in Patients With Pulmonary Arterial Hypertension [J].
Avriel, A. ;
Klement, A. H. ;
Johnson, S. R. ;
de Perrot, M. ;
Granton, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (10) :2705-2711
[45]   Pediatric donor management to optimize donor heart utilization [J].
Zimpfer, Daniel ;
Alexander, Peta M. A. ;
Davies, Ryan R. ;
Dipchand, Anne I. ;
Feingold, Brian ;
Joong, Anna ;
Lord, Karen ;
Kirk, Richard ;
Scales, Angie ;
Shih, Renata ;
Miera, Oliver .
PEDIATRIC TRANSPLANTATION, 2020, 24 (03)
[46]   Complement-Dependent Inflammation and Injury in a Murine Model of Brain Dead Donor Hearts [J].
Atkinson, Carl ;
Varela, Juan C. ;
Tomlinson, Stephen .
CIRCULATION RESEARCH, 2009, 105 (11) :1094-U112
[47]   National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? [J].
Dharmavaram, Naga ;
Hess, Timothy ;
Jaeger, Heather ;
Smith, Jason ;
Hermsen, Joshua ;
Murray, David ;
Dhingra, Ravi .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15)
[48]   Organ Dysfunction in Patients with Left Ventricular Impairment: What is the Effect of Cardiopulmonary Bypass? [J].
Jarral, Omar A. ;
Saso, Srdjan ;
Harling, Leanne ;
Ashrafian, Hutan ;
Naase, Hatam ;
Casula, Roberto ;
Athanasiou, Thanos .
HEART LUNG AND CIRCULATION, 2014, 23 (09) :852-862
[49]   Pediatric marginal donor hearts: Trends in US national use, 2005-2014 [J].
Morrison, Adam K. ;
Gowda, Charitha ;
Tumin, Dmitry ;
Phelps, Christina M. ;
Hayes, Don, Jr. ;
Tobias, Joseph ;
Gajarski, Robert J. ;
Nandi, Deipanjan .
PEDIATRIC TRANSPLANTATION, 2018, 22 (05)
[50]   The Effect of Ideal/Standard Donor and Marginal Donor Use on Primary Graft Dysfunction After Lung Transplantation in Turkey [J].
Turkkan, Sinan ;
Yilmaz, Emre ;
Bindal, Mustafa ;
Basaran, Fatmanur Celik ;
Sahin, Mehmet Furkan ;
Beyoglu, Muhammet Ali ;
Yazicioglu, Alkin ;
Yekeler, Erdal .
EURASIAN JOURNAL OF MEDICINE, 2023, 55 (01) :69-73